Vaccine trials in melanoma-time for reflection

Lex Eggermont

doi:10.1038/nrclinonc.2009.42

Vaccine trials in melanoma-time for reflection

Lex Eggermont

Surgery

Research output: Contribution to journal › Article › Academic › peer-review

32 Citations (Scopus)

Abstract

The disappointing results of the large, randomized, controlled trials showing no benefit of vaccines in patients with advanced and metastatic melanoma call for a reassessment of the development of therapeutic vaccines and the importance of better immune monitoring methodology, such as adoptive T-cell therapy with lymphodepletion.

Original language	Undefined/Unknown
Pages (from-to)	256-258
Number of pages	3
Journal	Nature Reviews Clinical Oncology
Volume	6
Issue number	5
DOIs	https://doi.org/10.1038/nrclinonc.2009.42
Publication status	Published - 2009

Research programs

EMC MM-03-47-11

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/nrclinonc.2009.42

http://hdl.handle.net/1765/16741

Cite this

@article{c79f075f5d3340918a7daacbb28fc5f4,

title = "Vaccine trials in melanoma-time for reflection",

abstract = "The disappointing results of the large, randomized, controlled trials showing no benefit of vaccines in patients with advanced and metastatic melanoma call for a reassessment of the development of therapeutic vaccines and the importance of better immune monitoring methodology, such as adoptive T-cell therapy with lymphodepletion.",

author = "Lex Eggermont",

year = "2009",

doi = "10.1038/nrclinonc.2009.42",

language = "Undefined/Unknown",

volume = "6",

pages = "256--258",

journal = "Nature Reviews Clinical Oncology",

issn = "1759-4774",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Vaccine trials in melanoma-time for reflection

AU - Eggermont, Lex

PY - 2009

Y1 - 2009

N2 - The disappointing results of the large, randomized, controlled trials showing no benefit of vaccines in patients with advanced and metastatic melanoma call for a reassessment of the development of therapeutic vaccines and the importance of better immune monitoring methodology, such as adoptive T-cell therapy with lymphodepletion.

AB - The disappointing results of the large, randomized, controlled trials showing no benefit of vaccines in patients with advanced and metastatic melanoma call for a reassessment of the development of therapeutic vaccines and the importance of better immune monitoring methodology, such as adoptive T-cell therapy with lymphodepletion.

U2 - 10.1038/nrclinonc.2009.42

DO - 10.1038/nrclinonc.2009.42

M3 - Article

C2 - 19390551

SN - 1759-4774

VL - 6

SP - 256

EP - 258

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

IS - 5

ER -